Publications

Export 11 results:
Author [ Title(Desc)] Type Year
Filters: Keyword is Double-Blind Method  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Fan Y, Herrera-Melendez ALucia, Pestke K, Feeser M, Aust S, Otte C, Pruessner JC, Böker H, Bajbouj M, Grimm S.  2014.  Early life stress modulates amygdala-prefrontal functional connectivity: implications for oxytocin effects.. Hum Brain Mapp. 35(10):5328-39.
Grimm S, Pestke K, Feeser M, Aust S, Weigand A, Wang J, Wingenfeld K, Pruessner JC, La Marca R, Böker H et al..  2014.  Early life stress modulates oxytocin effects on limbic system during acute psychosocial stress.. Soc Cogn Affect Neurosci. 9(11):1828-35.
Santisteban JA, Stein MA, Bergmame L, Gruber R.  2014.  Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.. CNS Drugs. 28(9):825-33.
Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.  2015.  Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.. J Alzheimers Dis. 48(2):473-81.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ et al..  2016.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.. Lancet. 388(10062):2873-2884.